Legacy medical devices face growing scrutiny as regulators push for stronger cybersecurity, transparency and risk management.
This three-part series reviews how the Food and Drug Administration’s (FDA) January 2026 guidance, “General Wellness: Policy for Low Risk ...
The US Food and Drug Administration’s (FDA) scrutiny around medical device cybersecurity will “intensify significantly” as we move into 2026, an expert has forecast. In June 2025, the agency published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results